51³Ô¹ÏÍø

Tag - astrazeneca

 
Menu
Search
 
July 24, 2026
 

Home Delivery
Subscribe for more access

ASTRAZENECA

U.S. President Donald Trump arrives to makes an announcement about lowering the cost of drug prices, at the Roosevelt Room of the White House in Washington on Dec. 19, 2025.
BUSINESS / Markets
Apr 1, 2026
Drugmakers delay some European launches with a wary eye on Trump¡¯s pricing policies
The White House has been pushing to lower the cost of prescription drugs in the U.S., which has traditionally paid significantly more than other wealthy countries.
AstraZeneca CEO Pascal Soriot with U.S. President Donald Trump during an announcement about lowering U.S. drug prices, at the White House in Washington on Friday.
BUSINESS / Companies
Oct 14, 2025
U.S. investments, and rhetoric, help AstraZeneca seal drug deal with Trump
Deal to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to November last year, sources say.
AstraZeneca and Daiichi Sankyo's drug Datroway extended survival in patients with a hard-to-treat form of breast cancer.
BUSINESS / Companies
Oct 7, 2025
Breast cancer patients lived longer on drug Datroway, says maker
The drug is said to have significantly improved survival and delayed disease progression in patients with a particularly hard to treat form of the disease.
AstraZeneca and Daiichi Sankyo¡¯s Datroway breast cancer treatment, which the companies expect will eventually become a blockbuster, was recommended for approval in the European Union.
BUSINESS
Jan 31, 2025
AstraZeneca and Daiichi¡¯s breast cancer drug gets EU backing
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan.
The U.S. Food and Drug Administration's approval of novel breast cancer treatment by Daiichi Sankyo and AstraZeneca led Daiichi Sankyo's shares to post the largest intraday gain since August on Monday.
BUSINESS / Companies
Jan 20, 2025
Daiichi Sankyo rises most in five months on cancer drug approval
Datroway, developed with AstraZeneca, has been approved for patients with advanced breast tumors.
Daiichi Sankyo's headquarters in Tokyo
BUSINESS
Jan 18, 2025
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
People walk past the AstraZeneca booth during the first China International Supply Chain Expo (CISCE) in Beijing on Nov. 28, 2023.
BUSINESS / Companies
Sep 16, 2024
AstraZeneca¡¯s blockbuster drug scores major win in combatting bladder cancer
In patients with muscle-invasive bladder cancer, the drug Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca¡¯s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite ¡®disappointing¡¯ trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
51³Ô¹ÏÍø / Science & Health
Aug 30, 2022
Japan OKs third Pfizer shot for children and AstraZeneca COVID treatment
Children between the ages of 5 and 11 will be able to get the booster shot five months or more after they received their second dose.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
51³Ô¹ÏÍø / Science & Health
Apr 11, 2022
Japan cancels purchase of 40 million Astrazeneca vaccine doses
The government had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.
51³Ô¹ÏÍø
Feb 7, 2022
Japan¡¯s booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
51³Ô¹ÏÍø / Explainer
Jan 6, 2022
The ins and outs of Japan¡¯s COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what¡¯s the rationale behind that strategy?
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It¡¯s suggested that Britain¡¯s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
51³Ô¹ÏÍø
Sep 14, 2021
Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors
Taiwan will get 500,000 more doses, bringing Japan¡¯s total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.
Japan Times
LIFE / Lifestyle
Aug 22, 2021
Here¡¯s how to treat COVID-19 vaccine side effects
There¡¯s no guarantee that you¡¯ll experience side effects from your COVID-19 vaccination, but it doesn¡¯t hurt to be prepared for them anyway.
51³Ô¹ÏÍø
Jul 30, 2021
Health ministry panel approves AstraZeneca¡¯s vaccine for people 40 and over
The panel also backed a proposal to make the shot available to people under age 40 who wish to get AstraZeneca¡¯s jab or who are allergic to the ingredients of the mRNA vaccines.
Japan Times
WORLD
Jul 22, 2021
Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds
The study reiterated that one shot of the vaccines is not enough for high protection from the highly transmissible variant.
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A team of researchers said they found a ¡°seed¡± that accelerates the amyloid beta accumulation process in the brain, naming it ¡°Peak 1 amyloid beta,¡± as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" ¡ª an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi¡¯s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan¡¯s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51³Ô¹ÏÍø

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER